Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sodium nitroprusside in the treatment of schizophrenia patients of acute symptoms
ChiCTR-OIC-16008216Phase 3Recruiting
- Sponsor
- The Second Affiliated Hospital of Xinxiang Medical University
- Start
- Apr 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of sodium nitroprusside in schizophrenia, sponsored by The Second Affiliated Hospital of Xinxiang Medical University. Primary endpoint: PANSS total score. Started Apr 2016; status: recruiting.
02
Drugs
sodium nitroprusside
03
Conditions
schizophrenia
Beyond the preview
Go deeper on ChiCTR-OIC-16008216.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-OIC-16008216.